Compared to commercial cell lines, primary GBM cell cultures more accurately represent the heterogeneity of tumors in patients, and the findings we obtained after targeting Src in different primary GBM cultures could benefit the further optimization of investigated STKIs. The gene discussed is SRC; the disease is glioblastoma.